Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CP.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.123 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XRNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.350.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.122NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.431NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.6 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.66NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used